Latest Helixmith News & Updates

See the latest news and media coverage for Helixmith. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Helixmith

Gene therapy development company

helixmith.com
Headquarters
Seoul, South Korea
Founded year
1996
Company type
Public company
Number of employees
50–200

Latest news about Helixmith

Company announcements

  • Helixmith

    Helixmith announces CEO presentation on ALS program DART

    Dr. Sunyoung Kim presents at 2022 Cell & Gene Meeting and BIO-Europe. DART investigates HGF/c-Met via plasmid DNA, AAV, and antibodies in parallel for ALS treatment.

  • Helixmith

    Helixmith announces topline results from Phase 2A ALS study

    Engensis high dose with repeated treatments is safe and well-tolerated. Primary safety endpoint achieved; no serious adverse events related to drug.

  • Helixmith

    Helixmith announces topline results from TADIOS COVID-19 study

    TADIOS proved safe and well-tolerated. IL-1RA levels decreased significantly, fatigue improved versus placebo. Study involved 100 subjects in India.

  • Helixmith

    Helixmith announces VM202 presentation at NYAS Advances in Pain Meeting

    Dr. John A. Kessler presents scientific basis and Phase 3 results for VM202 in painful diabetic peripheral neuropathy on May 3, 2022. VM202 shows significant pain reduction and safety.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Helixmith

Track Helixmith and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Helixmith competitors & trending companies

Browse news for competitors to Helixmith and other trending companies.